Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018
Fri, December 7, 2018
Thu, December 6, 2018
Wed, December 5, 2018
Tue, December 4, 2018
Mon, December 3, 2018
Fri, November 30, 2018
Thu, November 29, 2018
Wed, November 28, 2018
Tue, November 27, 2018
Mon, November 26, 2018

Derek Archila Downgraded (VNDA) to Hold and Held Target at $29 on, Dec 11th, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. hold-and-held-target-at-29-on-dec-11th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Oppenheimer, Downgraded "Vanda Pharmaceuticals Inc." (VNDA) to Hold and Held Target at $29 on, Dec 11th, 2018.

Derek has made no other calls on VNDA in the last 4 months.



There are 3 other peers that have a rating on VNDA. Out of the 3 peers that are also analyzing VNDA, 0 agree with Derek's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Derek


  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $47 on, Friday, December 7th, 2018
  • Charles Duncan of "Cantor Fitzgerald" Upgraded from Hold to Buy and Held Target at $43 on, Tuesday, December 4th, 2018
  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $26 on, Thursday, November 8th, 2018

Publication Contributing Sources